Forefront Analytics, LLC Danaher Corp Transaction History

Forefront Analytics, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$237.11 - $299.66 $174,750 - $220,849	-737 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$257.27 - $315.76 $189,607 - $232,715	737 New	737 $216,000
Q1 2021 May 13, 2021	SELL	$212.38 - $245.9 $196,663 - $227,703	-926 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$212.5 - $245.46 $18,700 - $21,600	-88 Reduced 8.68%	926 $206,000
Q3 2020 Nov 12, 2020	SELL	$177.16 - $215.33 $60,588 - $73,642	-342 Reduced 25.22%	1,014 $218,000
Q2 2020 Aug 10, 2020	BUY	$128.7 - $176.83 $149,420 - $205,299	1,161 Added 595.38%	1,356 $239,000
Q1 2020 May 11, 2020	BUY	$121.39 - $169.05 $23,671 - $32,964	195 New	195 $26,000

2,483

543M

7.08M

4.54M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $162B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.